Unlock instant, AI-driven research and patent intelligence for your innovation.
Composition and method conducive to acquiring follicular regulatory T cells in vitro and application of composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and regulatory technology, applied in the direction of biochemical equipment and methods, animal cells, vertebrate cells, etc.
Active Publication Date: 2017-09-19
ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF3 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, baicalin has not been found to promote Foxp3 + Related reports on Tfr differentiation
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0034] anti-CD3 / CD28 activated magnetic beads: purchased from Peprotech.
[0035] TGF-β: purchased from Peprotech, Cat. No. AF-100-21C.
[0036] IL-2: purchased from Peprotech Company, article number AF-212-12.
[0037] Baicalin: purchased from Tongtian Biology, dissolved in DMSO and prepared into solutions with different concentrations of 10 μM, 20 μM and 40 μM.
[0038]2. Methods and Results
[0039] 1. Baicalin combined with cytokines promotes the proliferation of Tfr cells:
[0040] Mononuclear cells were sorted from the spleen of MRL / lpr lupus mice, and naive T cells were sorted by immunomagnetic beads and cultured in vitro. On day 0, the sorted 2×10 6 naive CD4 + T cells were resuspended in a 24-well plate, the culture medium was RPMI1640 medium containing 10% fetal bovine serum, and anti-CD3 / CD28 activated magnetic beads (25 μl, the final concentration o...
Embodiment 2
[0048] To investigate the effects of different induction conditions on the proliferation of Tfr cells and the differentiation of naive T cells into Tfr.
[0051] anti-CD3 / CD28 activated magnetic beads: purchased from Peprotech.
[0052] TGF-β: purchased from Peprotech, Cat. No. AF-100-21C.
[0053] IL-2: purchased from Peprotech Company, article number AF-212-12.
[0054] Baicalin: purchased from Tongtian Biology, dissolved in DMSO and prepared into a solution of corresponding concentration.
[0055] 2. Method
[0056] 1. Group settings
[0057] The groups are shown in Table 1.
[0058] Table 1 Experimental grouping
[0059] group
[0060] 2. The proliferation of Tfr cells in different groups
[0061] Mononuclear cells were sorted from the spleen of MRL / lpr lupus mice, and naive T cells were sorted by immunomagnetic beads and cultured in vitro. On d...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a composition and a method conducive to acquiring follicular regulatory T cells in vitro and an application of the composition. The invention proves that differentiation and number proliferation of in-vitro Tfr (follicular regulatory T cells) can be effectively induced by the aid of irritation of TGF (transforming growth factor)-beta, IL (interleukin)-2, anti-CD3 antibodies, anti-CD28 antibodies and baicalin, and expression of Foxp3 in the Tfr is facilitated. The Tfr cells amplified by the method can be used for treating autoimmune diseases and chronic inflammatory diseases, the autoimmune diseases include lupus erythematosus, dermatomyositis, vasculitides, sicca syndrome, scleroderma, rheumatoid arthritis, ankylosing spondylitis, disseminated sclerosis and autoimmune hepatitis, and the chronic inflammatory diseases include diabetes, coronary heart diseases, hyperlipemia, eczema, vitiligos, atopic dermatitis, lichen planus and the like.
Description
technical field [0001] The present invention relates to inducing differentiation to obtain follicular regulatory T cells in vitro, in particular to a composition, method and application for obtaining follicular regulatory T cells in vitro. Background technique [0002] Follicular regulatory T cells (Tfr), surface marker CD4 + CXCR5 + , the transcription factors are Foxp3 and BCL-6, which are a group of T cells with immune regulation function existing in the germinal center and peripheral blood. Tfr derived from Foxp3 + In natural regulatory T cells (nTreg), Tfr can exert contact inhibition through CTLA-4 on the cellmembrane surface, and can also stimulate follicular helper T cells and B cells through secreted cytokines IL-10, TGF-β or perforin. Cells play an immunosuppressive role, inhibit the formation of germinal centers, autoantibodysecretion, and control the hyperactivity of humoral immunity; Tfr can also inhibit the proliferation and secretion of other effector T c...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
